HARLAN S ROBINS, the Chief Scientific Officer of $ADPT, sold 10,000 shares of the company on 11-10-2025 for an estimated $148,200. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.8% of their shares of this class of stock. Following this trade, they now own 1,269,524 shares of this class of $ADPT stock.
$ADPT Insider Trading Activity
$ADPT insiders have traded $ADPT stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ADPT stock by insiders over the last 6 months:
- CHAD M ROBINS (CEO and Chairman) has made 0 purchases and 3 sales selling 89,265 shares for an estimated $1,315,179.
- HARLAN S ROBINS (Chief Scientific Officer) sold 10,000 shares for an estimated $148,200
- KYLE PISKEL (Chief Financial Officer) sold 1,929 shares for an estimated $17,148
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ADPT Hedge Fund Activity
We have seen 143 institutional investors add shares of $ADPT stock to their portfolio, and 102 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RUBRIC CAPITAL MANAGEMENT LP removed 6,861,004 shares (-52.3%) from their portfolio in Q2 2025, for an estimated $79,930,696
- AMERIPRISE FINANCIAL INC removed 3,402,418 shares (-51.2%) from their portfolio in Q2 2025, for an estimated $39,638,169
- FRED ALGER MANAGEMENT, LLC added 2,355,427 shares (+inf%) to their portfolio in Q2 2025, for an estimated $27,440,724
- MILLENNIUM MANAGEMENT LLC removed 1,980,659 shares (-66.1%) from their portfolio in Q2 2025, for an estimated $23,074,677
- NIKKO ASSET MANAGEMENT AMERICAS, INC. removed 1,786,006 shares (-29.3%) from their portfolio in Q2 2025, for an estimated $20,806,969
- POINT72 ASSET MANAGEMENT, L.P. added 1,373,923 shares (+inf%) to their portfolio in Q2 2025, for an estimated $16,006,202
- JENNISON ASSOCIATES LLC added 1,215,715 shares (+1269.4%) to their portfolio in Q3 2025, for an estimated $18,187,096
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ADPT Analyst Ratings
Wall Street analysts have issued reports on $ADPT in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 11/06/2025
- JP Morgan issued a "Overweight" rating on 11/06/2025
- Piper Sandler issued a "Overweight" rating on 10/15/2025
- Guggenheim issued a "Buy" rating on 09/30/2025
- TD Cowen issued a "Buy" rating on 08/06/2025
- Craig-Hallum issued a "Buy" rating on 06/18/2025
To track analyst ratings and price targets for $ADPT, check out Quiver Quantitative's $ADPT forecast page.
$ADPT Price Targets
Multiple analysts have issued price targets for $ADPT recently. We have seen 8 analysts offer price targets for $ADPT in the last 6 months, with a median target of $18.5.
Here are some recent targets:
- Tejas Savant from Morgan Stanley set a target price of $16.0 on 11/11/2025
- Rachel Vatnsdal from JP Morgan set a target price of $20.0 on 11/06/2025
- Mark Massaro from BTIG set a target price of $21.0 on 11/06/2025
- David Westenberg from Piper Sandler set a target price of $20.0 on 10/15/2025
- Subbu Nambi from Guggenheim set a target price of $20.0 on 09/30/2025
- Dan Brennan from TD Cowen set a target price of $15.0 on 08/06/2025
- John Wilkin from Craig-Hallum set a target price of $15.0 on 06/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
